Business
Bounce Mobile Systems, Inc (BNCM) Announces Strategic Updates Following Merger with DELEX Healthcare Group Inc.
Bounce Mobile Systems, Inc (BNCM) Announces Strategic Updates Following Merger with DELEX Healthcare Group Inc..
About this update from Bounce Mobile Systems, Inc.
[{"type":"text","content":"April 09, 2025 – Taguig, Philippines — Bounce Mobile Systems, Inc. (OTC: BNCM), a publicly traded entity, is pleased to announce a series of key developments following the successful merger with DELEX Healthcare Group Inc. (“DELEX”), a leading healthcare provider in the Philippines.Merger Completion and Management TransitionThe merger between BNCM and DELEX was officially completed on October 8, 2024. In January 2025, DELEX began its full transition into BNCM’s corporate structure, taking the helm of day-to-day operations. The original BNCM team continues to serve in an advisory capacity, ensuring continuity in compliance and corporate governance throughout this exciting new chapter.Growth for the Past 15 Years DELEX has posted strong growth for the past 15 years and now has over 200 staffs, 30 Products approved by the Philippines FDA, supplies to over 900 Pharmacies and Hospitals, 160 Drug Chains and over 380 Dispensing Medical Doctors and Clinics.Retail Expansion Plans UnderwayDELEX, known for its rapid and strategic growth, opened its first pharmacy in 2021. Leveraging strong market momentum, DELEX now plans to expand its retail pharmacy presence to 60 branches nationwide. This initiative aligns with the company’s mission to make accessible and high-quality healthcare products available to more communities.Filing of Regulation A to Fuel GrowthTo support its expansion and capital requirements, DELEX intends to file a Regulation A offering with the Securities and Exchange Commission (SEC). This move will allow the company to raise additional funds while offering investors new opportunities to be part of its healthcare innovation journey.Updated Financial ReportingBNCM’s Q3 2024 financial statements have been updated to reflect DELEX’s operations, including its revenue streams, asset holdings, and liabilities. This transparent reporting ensures stakeholders are fully informed of the consolidated company's current performance. Post-Merger Share Structure and RebrandingFollowing the merger, DELEX now holds a majority 59.25% ownership of BNCM. BNCM shareholders maintain a 15.75% stake, with the remaining shares held by independent investors. To reflect its new identity, BNCM has filed for a name change to *DELEX Healthcare Group Inc.* and is in the process of updating its ticker symbol accordingly.Audit and Financial Over...